Selenium and colorectal adenomas risk: A meta-analysis

Nutrition and Cancer

Volumn 64, Issue 8, 2012, Pages 1153-1159

  Ou, Yiyi ^a   Jiang, Bei ^a   Wang, Xiaoli ^a   Ma, Wenling ^a   Guo, Junsheng ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; GLUTATHIONE PEROXIDASE; SELENIUM; SELENOPROTEIN P;

AGE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD LEVEL; CANCER PREVENTION; CANCER RISK; COLORECTAL ADENOMA; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; GENDER; HUMAN; META ANALYSIS; PLASMA; SERUM; SMOKING;

ADENOMA; CASE-CONTROL STUDIES; COHORT STUDIES; COLORECTAL NEOPLASMS; CROSS-SECTIONAL STUDIES; HUMANS; ODDS RATIO; RISK FACTORS; SELENIUM;

EID: 84873640537     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2012.722248     Document Type: Article

References (28)

1. Shamberger RJ and Frost DV: Possible protective effect of selenium against human cancer. Can Med Assoc J 100, 682, 1969.
2. Combs GF Jr and Gray WP: Chemopreventive agents: selenium. Pharmacol Ther 79, 179-192, 1998
3. Rayman MP: Selenium in cancer prevention: a review of the evidence and mechanism of action. Proc Nutr Soc 64, 527-542, 2005.
4. Novotny L, Rauko P, Kombian SB, and Edafiogho IO: Selenium as a chemoprotective anti-cancer agent: reality or wishful thinking? Neoplasma 57, 383-391, 2010.
5. Brozmanová J, Mániková D, Vlčková V, and Chovanec M: Selenium: a double-edged sword for defense and offence in cancer. Arch Toxicol 84, 919-938, 2010.
6. Rayman MP: Selenium in cancer prevention: a review of the evidence and mechanism of action. Proc Nutr Soc 64, 527-542, 2005.
7. Eide TJ: Risk of colorectal cancer in adenoma-bearing individuals within a defined population. Int J Cancer 38, 173-176, 1986.
8. Bond JH: Clinical evidence for the adenoma-carcinoma sequence, and the management of patients with colorectal adenomas. Semin Gastrointest Dis 11, 176-184, 2000.
9. Jänne PA, and Mayer RJ: Chemoprevention of colorectal cancer. N Engl J Med 342, 1960-1968, 2000.
10. Gustin DM and Brenner DE: Chemoprevention of colon cancer: current status and future prospects. Cancer Metastasis Rev 21, 323-348, 2002.
11. Higgins JP and Thompson SG: Quantifying heterogeneity in a metaanalysis. Stat Med 21, 1539-1558, 2002.
12. Clark LC, Hixson LJ, Combs GF Jr, Reid ME, Turnbull BW, et al.: Plasma selenium concentration predicts the prevalence of colorectal adenomatous polyps. Cancer Epidemiol Biomarkers Prev 2, 41-46, 1993.
13. Fernández-Bañares F, Cabré E, Esteve M, Mingorance MD, Abad-Lacruz A, et al.: Serum selenium and risk of large size colorectal adenomas in a geographical area with a low selenium status. Am J Gastroenterol 97, 2103-2108, 2002
14. Jacobs ET, Jiang R, Alberts DS, Greenberg ER, Gunter EW, et al.: Selenium and colorectal adenoma: results of a pooled analysis. J Natl Cancer Inst 96, 1669-1675, 2004.
15. Nelson RL, Davis FG, Sutter E, Kikendall JW, Sobin LH, et al.: Serum selenium and colonic neoplastic risk. Dis Colon Rectum 38, 1306-1310, 1995.
16. Russo MW, Murray SC, Wurzelmann JI, Woosley JT, and Sandler RS: Plasma selenium levels and the risk of colorectal adenomas. Nutr Cancer 28, 125-129, 1997.
17. Peters U, Chatterjee N, Church TR, Mayo C, Sturup S, et al.: High serum selenium and reduced risk of advanced colorectal adenoma in a colorectal cancer early detection program. Cancer Epidemiol Biomarkers Prev 15, 315-320, 2006.
18. Connelly-Frost A, Poole C, Satia JA, Kupper LL, Millikan RC, et al.: Selenium, apoptosis, and colorectal adenomas. Cancer Epidemiol Biomarkers Prev 15, 486-493, 2006.
19. Takata Y, Kristal AR, King IB, Song X, Diamond AM, et al.: Serum selenium, genetic variation in selenoenzymes, and risk of colorectal cancer: primary analysis from the Women's Health Initiative Observational Study and meta-analysis. Cancer Epidemiol Biomarkers Prev 20, 1822-1830, 2011.
20. Reid ME, Duffield-Lillico AJ, Sunga A, Fakih M, Alberts DS, et al.: Selenium supplementation and colorectal adenoma: an analysis of the nutritional prevention of cancer trial. Int J Cancer 118, 1777-1781, 2006.
21. Hofstad B, Almendingen K, Vatn M, Andersen SN, Owen RW, et al.: Growth and recurrence of colorectal polyps: a double-blind 3-year intervention with calcium and antioxidants. Digestion 59, 148-156, 1998.
22. Bonelli L, Camoriano A, Ravelli P, Missale G, Bruzzi P, et al.: Reduction of the incidence of metachronous adenomas of the large bowel bymeans of antioxidants. Proceedings of International Selenium Tellurium Development Association. Brussels, Belgium: Se-Te Press, 1998, pp. 91-94
23. Harrison I, Littlejohn D, and Fell GS: Distribution of selenium in human blood plasma and serum. Analyst. 121, 189-194, 1996.
24. Carmona-Fonseca J: Selenium in serum and plasma: epidemiology and reference value. Rev Panam Salud Publica 28, 388-398, 2010.
25. Thomson CD: Assessment of requirements for selenium and adequacy of selenium status: a review. Eur J Clin Nutr58, 391-402, 2004.
26. Moghadaszadeh B and Beggs AH: Selenoproteins and their impact on human health through diverse physiological pathways. Physiology 21, 307-315, 2006.
27. Papp LV, Lu J, Holmgren A, and Khanna KK: From selenium to selenoproteins: synthesis, identity, and their role in human health. Antioxid Redox Signal 9, 775-806, 2007.
28. Waters DJ, Chiang EC, Cooley DM, and Morris JS: Making sense of sex and supplements: differences in the anticarcinogenic effects of selenium in men and women. Mutat Res 551, 91-107, 2004.